EKLAMPSIYa V SOVREMENNOM AKUShERSTVE
- 作者: SAVEL'EVA GM1, ShALINA RI1, KURTsER MA1, ShTABNITsKIY AM1, KURTENOK NV1, KONOVALOVA OV1
-
隶属关系:
- 期: 编号 6 (2010)
- 页面: 4-9
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246353
- ID: 246353
如何引用文章
全文:
详细
The objective of the study was to define ways of reducing the frequency of eclampsia and its severe complications. The authors analyzed 113 histories of deliveries occurring in patients with severe gestosis and eclampsia at Moscow maternity homes in 2006-2008, the 2008 records of obstetric facilities of the Russian Federation, and the data available in the literature.
The main errors in the treatment of preeclampsia and eclampsia were the underestimation of the patients' status and no notification of the symptoms of preeclampsia (19-36%), insufficient and inadequate anticonvulsive therapy (13-85%), polypragmasia (56%), high administered fluid volumes with a predominance of colloids (25.4%), inadequate labor analgesia (82.7%), and inadequate postpartum therapy (12-87%). The reduction in the frequency of eclampsia and its complications is determined by the timely diagnosis and treatment of the conditions preceded its development. To follow the management protocols elaborated for patients with severe gestosis and eclampsia is excessively important
The main errors in the treatment of preeclampsia and eclampsia were the underestimation of the patients' status and no notification of the symptoms of preeclampsia (19-36%), insufficient and inadequate anticonvulsive therapy (13-85%), polypragmasia (56%), high administered fluid volumes with a predominance of colloids (25.4%), inadequate labor analgesia (82.7%), and inadequate postpartum therapy (12-87%). The reduction in the frequency of eclampsia and its complications is determined by the timely diagnosis and treatment of the conditions preceded its development. To follow the management protocols elaborated for patients with severe gestosis and eclampsia is excessively important
参考
- Геншер Г.Г. Учебник акушерства. - Л.: Биомедгиз, 1937.
- Интенсивная терапия. Национальное руководство / Под ред. Б.Р.Гельфанда, А.И.Салтанова - М.: ГЭОТАР-Медиа, 2009.
- Aagaard-Tillery K.M., Belfort M.A. Eclampsia: morbidity, mortality, and management. //Clin. Obstet. Gynecol. - 2005. - Vol.48. - P.12-23.
- Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. //Br. Med. J. - 1994. - Vol. 309. - P. 1395-400.
- Ducarme G., Herrnberger S, Pharisien I. et al. Eclampsia: retrospective study about 16 cases. // Gynecol. Obstet. Fertil. - 2009. - Vol.37, № 1. - Р. 11-17.
- Duley L. Maternal mortality associated with hypertensive disorders in pregnancy in Africa, Asia, Latin America and the Caribbean. // Br. J. Obstet. Gyraecol. - 1992. - Vol. 99. - P. 547-553.
- Lee W., O'Connell C.M., Baskett T.F. Maternal and perinatal outcomes of eclampsia: Nova Scotia, 19812000// J. Obstet. Gynaecol. Can. -2004. - Vol. 26, № 2. - Р. 119-123.
- Loureiro R., Leite C.C., Kahhale S. et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. //Am. J. Obstet. Gynecol. - 2003 - Vol. 189, № 5. - 1350-1355.
- Mattar F., Sibai B.M. Eclampsia. VIII. Risk factors for maternal morbidity. //Am. J. Obstet. Gynecol. - 2000 - Vol.182. - P. 307-312.
- Miguil M., Chekairy A. Eclampsia, study of 342 cases // Hypertension in pregnancy. - 2008 - Vol. 27. - 103-111.
- Obstetrics: normal and problem pregnancies/ Ed. S.G Gabbe. - 4-th ed. - Edinburg: Churchill Livingstone. - 2007.
- Sibai B.M. Diagnosis, prevention and management of eclampsia // Obstet. and Gynecol. - 2005. - Vol. 105. - P. 402-410.
- The Magpie Trial Collaboration Group. Do women with pre-eclampsia and their babies benefit from magnesium sulfate? The Magpie Trial: a randomised placebo-controlled trial // Lancet. - 2002. - Vol. 359, № 9321. - Р. 1877-1890.
- Zeeman G.G., Fleckenstein J.L., Twickler D.M. Cerebral infarction in eclampsia //Am. J. Obstet. Gynecol. - 2004. - Vol. 190, № 3. - Р. 714- 720
补充文件
![](/img/style/loading.gif)